Pr J.A. Sahel (chief of the «Institut de la Vision» — Inserm, CNRS, Université Paris VI), a member of the French Académie des Sciences, then presented a cell therapy phase I clinical trial project for retinitis
pigmentosa developed in collaboration with I - Stem.
Not exact matches
In addition to
developing therapies for AMD, my laboratory
develops therapies for retinitis
pigmentosa, diabetic retinopathy and more recently, uveitis; and I have significant interest in
developing technologies that can translate basic laboratory research into the clinic.
Bionic Vision Australia is a national consortium of researchers working together to
develop a bionic eye to restore vision to people with retinitis
pigmentosa and age - related macular degeneration.
A wireless epiretinal retina implant system, capable of stimulating the retinal ganglion cells in blind Retinitis
Pigmentosa (RP) patients, was
developed.